COVAXIN
Maharashtra to Import COVID-19 Vaccines from Other Countries, Divert Funds for Large-Scale Inoculation
Delhi Lockdown From April 20 To 26, Summer Vacation Announced Effective Immediately; CM Arvind Kejriwal Urges Migrant Workers Not To Leave The City
COVID-19 Vaccine To Be Allowed For All Above 18 Years Of Age Starting May 1, States Can Procure Directly
COVID-19 Vaccine Update: Augmentation of Manufacturing Capacity for COVAXIN Production Under Atmanirbhar Bharat 3.0 Mission COVID-19 Suraksha
COVID-19 Vaccine Update: Centre Clears Mumbai's Haffkine Institute to Make Covaxin Vaccine to Ramp Up Production
Human: Vipul Amrutlal Shah Plans to Visit Manufacturing Hub of Covaxin for His Series on COVID-19 Pandemic
Chhattisgarh Finally Starts Using ‘Covaxin’ Nearly Two Months After Launch of Nationwide COVID-19 Vaccination Drive
Covaxin, Bharat Biotech's COVID-19 Vaccine's Phase 2 Data In Lancet Magazine, It Says ‘It Is Safe, Induces Immune Response With No Severe Effects’
COVID-19 Vaccine Covaxin Phase 2 Data Shows Vaccine Safe, Induces Immune Response: Lancet Study
India Not Utilising COVID-19 Vaccine to Full Capacity, it is Either Donated or Sold Off to Foreign Countries, Says Delhi High Court
COVID-19 Vaccine Covaxin Shows 81% Efficacy in Phase 3 Clinical Trials, Says Bharat Biotech
Covaxin COVID-19 Vaccine Demonstrates Interim Clinical Efficacy of 81% in Phase 3 Trials, Claims Bharat Biotech
Google Trends